Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Gold IRA Companies
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Gold IRA Review
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
CABA
Stock Latest News
Company Announcements
Cabaletta Bio Hits Reset on RESET-MS Trial, Narrowing Near-Term Upside in Multiple Sclerosis
2d ago
CABA
Premium
Company Announcements
Cabaletta Bio Shareholders Approve Share Increase and Directors
16d ago
8K
CABA
Premium
Ratings
Buy Rating Reaffirmed on Robust Rese‑cel Autoimmune Data; $13 Price Target Reiterated as Cabaletta Advances Toward Commercialization
23d ago
CABA
Premium
Ratings
Cabaletta Bio: Buy Rating Reiterated as Rese-cel Data Strengthen Outpatient Cell Therapy Thesis; $16 Price Target Maintained
24d ago
CABA
Premium
The Fly
Cabaletta Bio presents new data for rese-cel in autoimmune diseases
24d ago
CABA
Premium
Company Announcements
Cabaletta Bio Highlights Rese-cel Data and Pivotal Path
24d ago
8K
CABA
Premium
Ratings
Douglas Tsao Reiterates Buy on Cabaletta Bio, Maintains $16 Price Target on Rese-cel’s Emerging Commercial Profile and Conditioning-Free Edge
1M ago
CABA
Premium
Ratings
Analyst Reiterates Buy on Cabaletta Bio Citing Strong Cash Runway and Promising Early Rese-cel Data in Autoimmune Diseases
1M ago
CABA
Premium
Ratings
Analyst Reiterates Buy on Cabaletta Bio, Citing Strong Non-Preconditioned PV Data, Scalable Manufacturing, and Multiple Upcoming Catalysts
1M ago
CABA
Premium
The Fly
Cabaletta Bio presents new clinical data for rese-cel
1M ago
CABA
Premium
The Fly
Cabaletta Bio reports Q1 EPS (39c), consensus (39c)
1M ago
CABA
Premium
Company Announcements
Cabaletta Bio Reports Encouraging RESET-PV Trial Data
1M ago
8K
CABA
Premium
Ratings
Cabaletta Bio Maintained at Buy as Emerging Rese-cel Data Support Preconditioning-Free Potential; $13 Price Target Reaffirmed
2M ago
CABA
Premium
The Fly
Cabaletta Bio financing overhang concerns should be addressed, says Cantor
2M ago
CABA
Premium
Company Announcements
Cabaletta Bio Announces $150 Million Equity Offering
2M ago
8K
CABA
Premium
Company Announcements
Cabaletta Bio reports promising RESET-PV and RESET-SLE data
2M ago
8K
CABA
Premium
Ratings
Cabaletta Bio: Buy Rating Reiterated as Rese-cel Data and Cellares Partnership Support Unchanged $16 Price Target
2M ago
CABA
Premium
The Fly
Cabaletta Bio, Cellares report 10-year commercial supply agreement for rese-cel
2M ago
CABA
Premium
The Fly
Cabaletta Bio, Cellares enter 10-year commercial agreement
2M ago
CABA
Premium
Ratings
Cabaletta Bio: RESET-MG Data and Differentiated Autoimmune Strategy Underpin Buy Rating and Upside Potential
2M ago
CABA
Premium
Company Announcements
Cabaletta Bio Updates rese-cel Autoimmune Therapy Development Plans
2M ago
8K
CABA
Premium
The Fly
Patients dosed with Cabaletta’s rese-cel manufactured on Cellares’ Cell Shuttle
2M ago
CABA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
